Highlights AdAlta Limited

Equities

1AD

AU0000001AD2

Delayed Australian S.E. Other stock markets 02:11:12 24/05/2024 BST			5-day change	1st Jan Change
0.026 ^AUD	0.00%		+8.33%	+8.33%

05-13	AdAlta Signs Master Services Agreement with Cell Therapies; Shares Up 4%	MT
04-29	AdAlta Secures Up to AU$3.7 Million for MOU, i-body Programs	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AdAlta Signs Master Services Agreement with Cell Therapies; Shares Up 4%	05-13	MT
AdAlta Secures Up to AU$3.7 Million for MOU, i-body Programs	04-29	MT
AdAlta Explores Cancer Immunotherapies Joint Venture for Western Market	04-08	MT
AdAlta Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-26	CI
AdAlta Receives AU$2.4 Million R&D Tax Rebate	18/10/23	MT
AdAlta Limited Reports Earnings Results for the Full Year Ended June 30, 2023	25/08/23	CI
Adalta Limited Announces Retirement of Elizabeth Mccall as Non-Executive Director	23/03/23	CI
AdAlta Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23	CI
AdAlta Secures Second Patent for I-body Candidate	10/01/23	MT
AdAlta Limited Provides an Update on Its Lead Program, AD-214	01/11/22	CI
AdAlta Limited & GPCR Therapeutics, Inc. to Evaluate CXCR4 I-Bodies in Cancer	12/10/22	CI
AdAlta Receives $1 Million R&D Tax Rebate	04/10/22	MT
AdAlta Limited Reports Earnings Results for the Full Year Ended June 30, 2022	29/08/22	CI
AdAlta Limited Modifies the Sequencing of AD-214 Manufacturing Campaigns and Toxicology Studies	03/07/22	CI
AdAlta Secures European Patent for Pulmonary Fibrosis Treatment	14/06/22	MT
Adalta Secures Indian Patent for Drug Targeting Platform	07/04/22	MT
Adalta Limited Finalizes Reclinical Development Program to Develop Inhaled Version of AD-214	04/04/22	CI
Adalta Secures Chinese Patent for Lead Program	02/03/22	MT
AdAlta Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22/02/22	CI
AdAlta Says Inhalable Fibrosis Drug Surpasses Study Expectations	09/12/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AdAlta Limited

Equities

1AD

AU0000001AD2

Highlights

Filters